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Abstract
Refugees and internally displaced persons in humanitarian settings are particularly susceptible to the spread of
infectious illnesses such as COVID-19 due to overcrowding and inadequate access to clean water, sanitation, and
hygiene facilities. Countries facing conflict or humanitarian emergencies often have damaged or fragmented health
systems and little to no capacity to test, isolate, and treat COVID-19 cases. Without a plan to address COVID-19 in
humanitarian settings, host governments, aid agencies, and international organizations risk prolonging the spread
of the virus across borders, threatening global health security, and devastating vulnerable populations. Stakeholders
must coordinate a multifaceted response to address COVID-19 in humanitarian settings that incorporates
appropriate communication of risks, sets forth resource-stratified guidelines for the use of limited testing, provides
resources to treat affected patients, and engages displaced populations.
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Background
The COVID-19 outbreak has indiscriminately spread
across the world, including in countries facing ongoing
conflict, protracted humanitarian crises, and large num-
bers of forcibly displaced individuals. Countries experi-
encing humanitarian emergencies are particularly
vulnerable to the spread of infectious diseases and have
limited capacity to confront the challenges associated
with containing the spread of COVID-19 and treating
existing cases. Despite this reality, aid agencies, inter-
national actors, and donor governments have been slow
to coordinate a multifaceted response, and few policies
have been put forth to develop sufficient test-treat-
isolate capacity and to equip medical facilities and health
personnel with the resources necessary to care for pa-
tients with COVID-19. Although the Global
Humanitarian Response Plan for COVID-19 sets forth
an important strategic framework to address the virus,
countries in humanitarian settings still face immense
gaps in their capacity to implement proposed solutions
[1]. Without further coordinated global assistance to
support context-specific solutions in countries affected
by humanitarian crises, there is considerable risk that
COVID-19 will devastate vulnerable populations of dis-
placed individuals, continue to spread across borders,
and threaten global health security. This call-to-action
highlights the challenges of addressing COVID-19 in hu-
manitarian settings and presents key recommendations
for national governments, international agencies, and
humanitarian responders to control the spread of
COVID-19 and treat severely infected patients given lim-
ited resources.
Main text
Heightened risks of the impact of COVID-19 in crisis
settings
Despite global calls to support low-to-middle income
countries in addressing COVID-19, little attention has
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been given to refugees and internally displaced persons
(IDPs) in humanitarian contexts, particularly those living
in camps or informal settings. Refugees and IDPs are often
forced into settlements with high population densities, and
these overcrowded areas tend to have limited public health
services, poor sanitation and waste disposal facilities, and in-
adequate access to clean water – making them particularly
susceptible to a COVID-19 outbreak. According to the
United Nations High Commissioner for Refugees, approxi-
mately 84% of the 70 million individuals who have been
forced to flee their homes are hosted by low-to-middle in-
come countries with weak health systems and water, sanita-
tion, and hygiene (WASH) tools [2]. Of the countries with
reported cases of COVID-19, over thirty play host to regis-
tered refugee populations of over 20,000 people, in addition
to a considerable number of unregistered refugees [3]. Ap-
proximately 80% of refugees seek work or reside in urban
areas, and refugees or humanitarian responders who travel
from overcrowded settlements to cities to seek healthcare or
work could worsen the spread of the virus [4]. The United
Nations has already ordered the evacuation of Moria refugee
camp in Lesbos, Greece, which was designed to host 3000
people but now hosts over 20,000 and has been reported to
have widespread malnutrition and poor hygiene [5]. In more
established camps such as that of Cox’s Bazar in Bangladesh,
which hosts half a million Rohingya refugees, it is likely that
the spread of COVID-19 will still pose challenges as the
management of cases requires referrals to health facilities
that are already overstretched.
The scientific community has continued to make ad-
vances in understanding the most effective ways to man-
age severe cases of COVD-19, most recently with the
publication of a clinical trial on the use of dexametha-
sone [6]. It is known that COVID-19 is transmitted via
aerosolized particles, larger droplets, and sustained con-
tact with contaminated surfaces and that severe cases
often result in an overwhelming inflammatory response
affecting the lungs. Data from affected countries suggest
that age (> 65), one or more serious comorbidities, par-
ticularly cardiovascular disease or uncontrolled diabetes,
and smoking are correlated with increased rates of mor-
tality [7, 8]. Data from the Centers for Disease Control
and Prevention also show that approximately 55% of pa-
tients aged 20–64 are at risk for moderate to severe in-
fection and require respiratory support in the form of
oxygen via nasal cannula, positive pressure ventilation,
or in the worst cases, mechanical ventilation [9]. Despite
these daunting statistics, the majority of COVID-19
cases are asymptomatic or present with mild symptoms,
such as a cough and congestion. This trend is expected
to hold true among refugees and IDPs as well. However,
it is not yet clear if there are particular health and social
characteristics specific to these vulnerable groups which
will result in higher rates of transmission and mortality,
especially among younger age groups. The actual burden
of COVID-19 in areas hosting refugees and IDPs is still
unknown given a serious lack of testing capabilities. Due
to overcrowding, poor WASH tools, and limited avail-
ability of advanced health services, it is expected that
rates of transmission and mortality will be higher in hu-
manitarian settings. In Somalia, documentary sources
claim that nearly 70% of daily tests are returning positive
as the country surpasses 3000 reported cases [10].
For severely infected patients, hospitalization, respira-
tory support, and even cardiac resuscitation may be ne-
cessary, in addition to continued management of
chronic comorbid conditions such as cancer and cardio-
vascular disease that are increasingly prevalent in hu-
manitarian settings [11, 12]. These patients will likely
struggle immensely to receive care in such contexts
given that the majority of conflict-affected nations with
large populations of IDPs and refugees do not have the
health infrastructure nor the medical personnel to pro-
vide these services. In humanitarian contexts, hospitals
have been destroyed; medical personnel have been killed
or displaced; and, the provision of medical supplies, in-
cluding personal protective equipment (PPE) required to
prevent COVID-19 transmission, is inadequate [13]. In
Syria, for example, only 64% of hospitals and approxi-
mately 52% of primary care centers are still functional
[14]. It must also be noted that most available research
and interventions using anti-viral medications, such as
Remdesivir and steroids for cytokine storm, have been
developed against a backbone of high-income and high-
dependency intensive care, which are rarely available in
humanitarian settings.
Upholding international frameworks and protecting
global health security
Many of the nations that host the majority of the world’s
refugees are signatories to the 1951 UN Refugee Con-
vention and its 1967 Protocol or similar regional frame-
works that state that refugees should receive the same
health services as nationals [15]. Given these inter-
national commitments and the necessity of treating all
affected populations to contain the spread of COVID-19,
refugees and IDPs must be included in national response
plans. Furthermore, the COVID-19 pandemic can affect
anyone, regardless of race, gender, age, or political affili-
ation. Like all infectious pathogens, COVID-19 has no
regard for national borders. Given the transient nature
of populations in crisis settings, an inadequate response
to COVID-19 in such settings is likely to prolong the
spread of the virus and threaten global health security.
As such, it is the collective responsibility of global
leaders and international organizations to coordinate a
robust response to prevent the spread of COVID-19 and
treat affected patients in humanitarian settings.
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COVID-19 response priorities in humanitarian settings
There is much that should be done to address COVID-
19 in humanitarian settings. First, governments, aid
agencies, and international actors must put forth clear
prevention and treatment options that are consistent
with available resources. To reduce transmission of this
highly contagious pathogen, there needs to be effective
communication of risks to both affected populations and
front-line responders, explaining how the virus is trans-
mitted, the importance of handwashing, sanitation, and
hygiene in reducing transmission, and the necessary
steps to take if there is concern for infection. Only then
can stakeholders work together to further prevent trans-
mission by implementing physical distancing measures,
restructuring settlements, and improving the availability
of WASH, as dictated by the World Health Organiza-
tions response guidelines [16]. Second, given the reality
of inadequate laboratory access in crisis settings,
resource-stratified guidelines for the use of limited test-
ing must be put forth to identify cases and prevent fur-
ther transmission. The mistakes of severely affected
countries and the successes of countries who have been
able to avoid and reduce transmission have taught us
that early and broad testing is imperative to controlling
the spread of this virus. Until widespread testing is avail-
able, governments and humanitarian agencies must pro-
vide explicit guidance for the use of limited tests,
perhaps prioritizing at-risk populations and healthcare
workers. Third, because it is expected that transmission
will not be well-controlled in some settings, there must
be a context-specific preparedness plan for case manage-
ment. In addition to ensuring the availability of resources
that could be potentially life-saving, such as PPE for health-
care workers, oxygen tanks, nasal cannulas, and ventilators
when possible, this is a setting where mobilizing additional
healthcare professionals, creating mobile screening sites, and
establishing temporary healthcare facilities would be effective
in treating a potential surge of acutely ill patients. It may be
more practical to have safe wards supporting non-invasive
respiratory needs as opposed to sophisticated intensive care
technologies that are not likely to be the best use of limited
resources. In the worst case, providers in these settings
should be ready to employ mass-casualty tagging techniques
if spread is rampant and mortality rates increase [17]. If re-
sources are limited and patients are expectant, frank conver-
sations must be had to determine the patient’s goals of care
along the spectrum of illness. In spite of the limited availabil-
ity of treatment resources for COVID-19, however, frontline
responders should not divert resources away from already
necessary life-saving health services, such as emergency ob-
stetrics and vaccination. Lastly, given the immense demand
for health practitioners, the COVID-19 pandemic provides
an opportunity to review national healthcare policies and in-
tegrate refugees into national health systems, allowing
displaced healthcare workers to practice and fill human re-
source gaps.
Conclusions
A call to action
It is well known by now that COVID-19 is highly conta-
gious and will spread quickly in humanitarian settings,
particularly in confined and crowded camp settings. In
fact, this may be occurring already, but due to limited
testing capacity for COVID-19 infection in such settings,
there is no way to assess the current burden. Without a
strategy to identify cases of COVID-19, to mitigate the
spread of infection, and to treat affected patients, the
rapid transmission and ultimate death of thousands of
people in humanitarian settings becomes an inevitable
and unspoken truth of this pandemic [18]. If this was
not enough motivation, the spread of infection, particu-
larly in urban areas, is linked to cases among the most
vulnerable. While global health agendas and inter-
national policies often only effectively protect some, it is
clear now, more than ever, that the outcomes of some
are inextricably linked to the outcomes of all. Our con-
nectedness is undeniable, and inaction in addressing
COVID-19 in humanitarian settings may threaten global
health security moving forward. In order to achieve the
response priorities highlighted, national governments,
international agencies, and humanitarian organizations
must promptly collaborate to develop context-specific
strategies to promote risk communication, prioritize the
use of existing testing kits and increase their overall
availability, provide resources to treat affected patients,
and engage displaced populations. While addressing
COVID-19 in humanitarian settings may appear to be
an acute challenge, stakeholders, especially national gov-
ernments and international donors, can consider com-
mitments to combatting COVID-19 as long-term
investments in the success of a given country’s health
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